Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | QXL138AM |
Trade Name | |
Synonyms | |
Drug Descriptions |
QXL138AM is an immunocytokine comprising an anti-CD138 antibody fused to a masked IFNalpha2a that is unmasked by proteases in the tumor microenvironment, which increases interferon signaling and cytokine release and potentially inhibits growth of CD138-expressing tumors (Journal for ImmunoTherapy of Cancer 2023;11). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
QXL138AM | QXL138AM | 0 | 1 |